Status:

COMPLETED

A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions

Lead Sponsor:

University Hospital, Tours

Conditions:

Breast Tumors

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Ultrasound is a well-established imaging modality for the evaluation of breast disease. The investigators' objective is to characterise the properties of an intravascular ultrasonographic contrast ag...

Detailed Description

The main objective of the study is to evaluate the efficacy of SonoVue® to detect breast lesions and define specific microcirculation patterns in patients with four different type of breast lesions (e...

Eligibility Criteria

Inclusion

  • 18 years of age or older
  • Woman presenting with: enlarging fibroadenoma (less than 2 cm in diameter or woman over 40 years old with fibroadenoma less than 2 cm in diameter) or suspect malignant nodule (less than 2 cm in diameter) or a cluster of microcalcification or a malignant nodule (size greater than 3 cm) diagnosed with mammography and/or MRI and/or United States (US) examination performed within 1 month before the study.
  • Woman scheduled for biopsy or surgery within 1 month from the examination.

Exclusion

  • Patients who have already performed a biopsy on the lesion during investigation
  • Any contraindication to perform a contrast-enhanced MRI examination for the patients presenting with a malignant nodule (size greater than 3 cm)
  • Patients previously entered in this study or having received an investigational drug within 30 days prior to admission to this study
  • Patients with any medical condition or other circumstances which would significantly decrease the chances of obtaining reliable data or of achieving the study objectives (drug dependence, psychiatric disorders, dementia or other reasons)
  • Pregnant or nursing female
  • Patient known to have a coronary syndrome
  • Unstable angina and myocardial infarction
  • Acute cardiac failure, Class III/IV cardiac failure
  • Severe rhythm disorders
  • Acute endocarditis
  • Prosthetic valves

Key Trial Info

Start Date :

May 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

59 Patients enrolled

Trial Details

Trial ID

NCT00243698

Start Date

May 1 2004

End Date

May 1 2007

Last Update

November 22 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Tours

Tours, France, 37044